US regulators approve first digital pill to track patients - InfoNews

Current Conditions

Mostly Cloudy
20.7°C

US regulators approve first digital pill to track patients

FILE - This Oct. 14, 2015, file photo, shows the U.S. Food & Drug Administration campus in Silver Spring, Md. On Monday, Nov. 13, 2017, the FDA approved the first drug in the United States with a digital ingestion tracking system, in an unprecedented move to ensure that patients with mental illness take the medicine prescribed for them. The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd.
Image Credit: (AP Photo/Andrew Harnik, File)
November 14, 2017 - 1:52 PM

WASHINGTON - U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.

The digital pill approved Monday combines two existing products: the former blockbuster psychiatric medication Abilify — long used to treat schizophrenia and bipolar disorder — with a sensor tracking system first approved in 2012.

The technology is intended to help prevent dangerous emergencies that can occur when patients skip their medication, such as manic episodes experienced by those suffering from bipolar disorder.

But developers Otsuka Pharmaceutical Co. and Proteus Digital Health are likely to face hurdles. The pill has not yet been shown to actually improve patients' medication compliance, a feature insurers are likely to insist on before paying for the pill. Additionally, patients must be willing to allow their doctors and caregivers to access the digital information.

These privacy issues are likely to crop up more often as drugmakers and medical device companies combine their products with technologies developed by Silicon Valley.

The new pill, Abilify MyCite, is embedded with a digital sensor that is activated by stomach fluids, sending a signal to a patch worn by the patient and notifying a digital smartphone app that the medication has been taken.

The FDA stressed however that there are limitations to monitoring patients.

"Abilify MyCite should not be used to track drug ingestion in 'real-time' or during an emergency," the statement said, "because detection may be delayed or may not occur."

Patients can track their dosage on their smartphone and allow their doctors, family or caregivers to access the information through a website.

In a statement issued last May at the time the FDA accepted submission of the product for review, the companies said "with the patient's consent, this information could be shared with their healthcare professional team and selected family and friends, with the goal of allowing physicians to be more informed in making treatment decisions that are specific to the patient's needs."

While it's the first time the FDA has approved such a pill, various specialty pharmacies and hospitals in the U.S. have previously "packaged" various drugs and sensors. But the federal endorsement increases the likelihood that insurers will eventually pay for the technology.

Drugmakers frequently reformulate their drugs to extend their patent life and to justify raising prices. For instance, Otsuka already sells a long-acting injectable version of Abilify intended to last for one month. The patent on the original Abilify pill expired in 2015.

The Japanese drugmaker has not said how it will price the digital pill. Proteus Digital Health, based in Redwood City California, makes the sensor.

News from © The Associated Press, 2017
The Associated Press

  • Popular penticton News
  • Comments
  • Woman found dead in car in Kamloops
    KAMLOOPS - A woman has been found dead and two men have been taken to hospital after they were found in a car playing loud music early this morning. Kamloops RCMP spokesperson Cpl. Jodi Shel
  • Kamloops RCMP seek missing man
    KAMLOOPS - Police in Kamloops are asking for the public's help to find a missing man. James Harris, 53, has not been in contact with family or friends since late March and he was last se
  • Searching for a stranger: Dozens of people brought in by bus to look for Ryan Shtuka
    SUN PEAKS - It's been nearly 10 weeks since Ryan Shtuka went missing in the Sun Peaks area after leaving a house party on Burfield Drive, but volunteers are still showing up in droves hoping t
  • Kelowna RCMP investigating brutal downtown assault
    KELOWNA - A Kelowna man who witnessed a brutal assault by a group of young men on a lone male in downtown Kelowna on the weekend says he feels like he came close to seeing a murder in progress.
  • Broncos families surprised obituaries are on website selling services
    Some families of Humboldt Broncos bus crash victims are surprised to learn that error-riddled obituaries of their loved ones have been posted on a website that's selling flowers, as well as on
View Site in: Desktop | Mobile